Simulation Training to Improve Informed Consent and Pharmacokinetic/ Pharmacodynamic Sampling in Pediatric Trials

Simulation Training to Improve Informed Consent and Pharmacokinetic/ Pharmacodynamic Sampling in Pediatric Trials
Bjoern B. Burckhardt, Agnes Maria Ciplea, Anna Laven, László Ablonczy, Ingrid Klingmann, Stephanie Läer, Karl Kleine, Michiel Dalinghaus, Milan Ðukic, Johannes M. P. J. Breur, Marijke van der Meulen, Vanessa Swoboda, Holger Schwender, Florian B. Lagler
Frontiers of Pharmacology, December 2020; 11
Open Access
Abstract
Background
Paediatric trials to add missing data for evidence-based pharmacotherapy are still scarce. A tailored training concept appears to be a promising tool to cope with critical and complex situations before enrolling the very first patient and subsequently to ensure high-quality study conduct. The aim was to facilitate study success by optimizing the preparedness of the study staff shift.
Method
An interdisciplinary faculty developed a simulation training focusing on the communication within the informed consent procedure and the conduct of the complex pharmacokinetic/pharmacodynamic (PK/PD) sampling within a simulation facility. Scenarios were video-debriefed by an audio-video system and manikins with artificial blood simulating patients were used. The training was evaluated by participants’ self-assessment before and during trial recruitment.
Results
The simulation training identified different optimization potentials for improved informed consent process and study conduct. It facilitated the reduction of avoidable errors, especially in the early phase of a clinical study. The knowledge gained through the intervention was used to train the study teams, improve the team composition and optimize the on-ward setting for the FP-7 funded “LENA” project (grant agreement no. 602295). Selfperceived ability to communicate core elements of the trial as well as its correct performance of sample preparation increased significantly (mean, 95% CI, p ≤ 0.0001) from 3 (2.5–3.5) to four points (4.0–4.5), and from 2 (1.5–2.5) to five points (4.0–5.0).
Conclusion
An innovative training concept to optimize the informed consent process and study conduct was successfully developed and enabled high-quality conduct of the pediatric trials as of the very first patient visit.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s